Abstract
Fetal anemia is a rare but potentially life-threatening condition requiring intrauterine transfusion (IUT). Neonates treated with IUT remain at risk of late postnatal hyporegenerative anemia. We aimed to evaluate whether fetal hemoglobin (HbF) measured through routine newborn screening (NBS) could provide information about the risk of postnatal anemia and red blood cell (RBC) transfusion in neonates treated with IUT. Fifty fetuses who underwent at least one IUT between 2016 and 2025 at two tertiary referral centers were included. HbF measured through NBS was compared between IUT-treated neonates who did and did not require postnatal RBC transfusion and healthy newborn controls. Of the 43 live-born neonates, 35% required postnatal RBC transfusion; 27% of these developed anemia during follow-up after not being anemic at birth. HbF levels were lower in neonates requiring postnatal RBC transfusion than in those who did not and were also lower than in healthy controls (p < 0.001). The interval between the last IUT and birth was positively associated with HbF (β = 3.7, p = 0.001). Lower HbF levels at NBS were associated with a higher risk of postnatal anemia and RBC transfusion. HbF may help identify neonates who require closer hematologic monitoring after IUT.